Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Libevitug - Huahui Health

Next Previous
Drug Profile

Libevitug - Huahui Health

Alternative Names: HH-003

Latest Information Update: 29 May 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Huahui Health
  • Class Antiretrovirals; Antivirals; Monoclonal antibodies
  • Mechanism of Action Hepatitis B surface antigen presurface protein 1 inhibitors; Virus internalisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Registered Hepatitis D
  • Discontinued Hepatitis B

Most Recent Events

  • 22 Apr 2026 Phase-III clinical trials in Hepatitis D (In adolescents, In adults, In the elderly, Treatment-experienced) in China (IV) (NCT07499544)
  • 25 Mar 2026 Huahui Health plans a phase III D-clear Study for Hepatitis D (Treatment-experienced)(Intravenous, infusion) (NCT07499544)
  • 28 Jan 2026 Discontinued - Phase-II for Hepatitis B (Combination therapy, Treatment-experienced) in China (IV), before January 2026 (Huahui Health pipeline, January 2026)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top